Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL9638545

CC(=O)CC(=O)NS(=O)(=O)O.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.46
FNTB P49356 1/20 0.46
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
ACP1 P24666 2/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
KDM6B O15054 1/20 0.32
KDM5C P41229 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3182370 0.97 FNTA (0.47) FNTAFNTBCA1CA2CA4
SCHEMBL28205206 0.97 FNTA (0.47) FNTAFNTBCA1CA2CA4
Fluoride SCHEMBL10492292 0.95 FNTA (0.46) FNTAFNTBCA1CA2CA4
SCHEMBL27257292 0.95 FNTA (0.46) FNTAFNTBCA1CA2CA4
Trimethylammonium SCHEMBL10838652 0.90 FNTA (0.43) FNTAFNTBCA1CA2CA4
SCHEMBL28257083 0.88 FNTA (0.42) FNTAFNTBCA1CA2CA4
Tert-Butylamine SCHEMBL10837638 0.86 FNTA (0.41) FNTAFNTBCA1CA2CA4
Tert-Butylamine SCHEMBL10375334 0.86 FNTA (0.41) FNTAFNTBCA1CA2CA4
SCHEMBL10838775 0.84 FNTA (0.40) FNTAFNTBCA1CA2CA4
SCHEMBL10969272 0.84 FNTA (0.40) FNTAFNTBCA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5103046-A PROCESS FOR THE PREPARATION OF 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE 2,2-DIOXIDE AND ITS NON-TOXIC SALTS, AND THE ACETOACETAMIDE-N-SULFONIC ACID (SALTS) WHICH OCCUR AS INTERMEDIATE(S) IN THIS PROCESS HOECHST AKTIENGESELLSCHAFT (DE) 1992-04-07 US disclosed
US-5011982-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts and the acetoacetamide-n-sulfonic acid (salts) which occur as intermediate(s) in this process HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-30 US disclosed
EP-0155634-B1 PROCESS FOR THE PREPARATION OF 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE 2,2-DIOXIDE AND OF ITS NON-TOXIC SALTS, AS WELL AS OF ACETOACETAMIDE-N-SULFONIC ACID OCCURRING AS AN INTERMEDIARY IN THIS PROCESS, AND ITS SALTS HOECHST AKTIENGESELLSCHAFT (DE) 1990-06-13 EP disclosed
US-4695629-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-22 US disclosed
US-4607100-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1986-08-19 US disclosed